Assessment of physical activity during and post allogenic haematopoetic cell transplantatio

• Conditions: patients undergoing allogeneic haematopoetic cell transplantation (HCT); C81-C96; Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue

• Registration Number: DRKS00004342
• Lead Sponsor: IVERSITÄTSKLINIKUM FREIBURGKlinik für Innere Medizin ISchwerpunkt Hämatologie, Onkologie und Stammzelltransplantation

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2013-01-04
• Study Completion: 2013-12-31
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 15

Inclusion Criteria

adult patients undergoing alloHCT (18 years old)
- patient's information followed by written consent

Exclusion Criteria

non

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
- activity-time per activity-category (min/day) measured among the inpatient period of time during alloHCST (approx. 40 days) with a three-dimensional accelerometer (Aipermon 440 PC, Aipermon GmbH & Co.KG, München)

Secondary Outcome Measures

Name	Time	Method
- walking-distance (m/day) measured by a three-dimensional accelerometer (Aipermon 440 PC, Aipermon GmbH & Co.KG, München)<br>- physical activity level (metabolic equivalent of task [MET]) per week before and during therapy start measured by a questionnaire for phyical activity [FFKA: Freiburger Fragebogen zur körperlichen Aktivität]<br>- body composition measured by body-impedance-analysis (°, %, kg) (Nutrigard MS®, Data Input GmbH, Darmstadt)<br>- muscle size m. quadriceps femoris (cm) measured by sonography (Siemens Sonoline G40, 10.5.MHz, Germany)<br>- blood parameter documentation<br>